News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

genOway Takes Over Transgenic Commercial Activities Of IngenKO Pty Ltd



10/19/2005 5:13:21 PM

Lyon, France - 13th October 2005 - genOway, the European market leader in transgenesis, takes over commercial activities for IngenKO Pty Ltd following the Australian company's closure. This confirms genOway's leading position in the market and contributes to the worldwide expansion of the company's activities.

IngenKO was set up in June 2001 as a spin-off company of Monash University, a renowned academic institute and a leader in stem cell research. The company gained 4 years experience as a commercial supplier of gene-targeted mice on a service-fee basis to customers in the academic, pharmaceutical, biotechnology and medical research communities in Australia, the USA, Europe, Japan and Asia. IngenKO was one of the major players in this very competitive market.

Prior to IngenKO's closing, genOway was contacted to facilitate the transfer of a number of projects, "With a high production capacity, and high quality services, genOway was the obvious choice to complete the IngenKO's projects. IngenKO's customers welcomed this transfer of supplier, as they were reassured by genOway's expertise and market position." said Dr Rocco Iannello, Business Development Manager, Monash Institute of Medical Research, Monash University.

Based in Lyons, France and Hamburg,, Germany, genOway is the European market leader in transgenesis. genOway's mission is to provide pharmaceutical and academic research institutes with tailor-made genetically modified animal models for gene validation, drug screening, pharmacological and toxicological studies. With highly skilled staff, innovative technologies and genuine customer oriented service offers, the relevancy of the business model developed by genOway is confirmed by its worldwide expansion and its expert position on the market. "The transfer of IngenKO's commercial activities to genOway is a further confirmation of the trust that various players in this market place in genOway's leadership. We are very proud to have been chosen by IngenKO. Every single customer of IngenKO entrusted us to complete their projects," said Alexandre Fraichard, genOway's CEO.

About genOway www.genoway.com Based in Lyons, France and Hamburg, Germany genOway is a service provider fully dedicated to the development of tailor made transgenic mouse and rat models. The company has established business relationships with renowned academic research centres among which Harvard Medical School, Imperial College London, King's College London, Ludwig Institute for Cancer Research, Max Planck Institute for Molecular Biomedicine, Netherlands Institute for Developmental Biology, Pasteur Institute are a few to mention. The company works also with major biotech companies and leading pharmaceuticals companies. With 50 full-time employees and operating in 20 countries in Europe, North America and Asia, genOway is, with respect to staff and clients, the largest company in its field in Europe. 40 experienced biologists (15 PhDs and 25 technicians) are exclusively concentrated on designing models, molecular biology, cell biology and embryology. All animal-related services are subcontracted to the world's leader animal breeder Charles River Laboratories that ensures animal breeding, housing, health status certification as well as worldwide delivery.

For further information, please contact: Gilles de Poncins ,CFO Phone : +33 (0)4 37 65 47 00 E-mail: info@genoway.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES